FDA MedWatch: Children Born to Mothers who took Valproate Products While Pregnant may have Impaired Cognitive Development

July 1, 2011


The FDA notified healthcare professionals that children born to mothers who take the anti-seizure medication valproate sodium or related products (valproic acid and divalproex sodium) during pregnancy have an increased risk of lower cognitive test scores than children exposed to other anti-seizure medications during pregnancy.

Read the FDA MedWatch safety alert.